products participated in an interlaboratory study of aspartate aminotransferase (EC 2.6.1.1) methodologies. Six different lyophilized materials were prepared and characterized and then distributed to 293 laboratories for aspartate aminotransferase measurements. The specimens included one human serum; four catalytic concentrations of the cytoplasmic isoenzyme, two purified from human erythrocytes, and two from porcine heart; and one matrix bovine serum albumin (30 g/liter) blank. The purified isoenzymes were prepared in the matrix. We present data on Michaelis parameters (Km and V), Arrhenius plots, activation with pyridoxal 5-phosphate, vial-to-vial variability, and stability on reconstitution. The 281 responses showed that most of the laboratories used NADH detection methods (91.1 %), monitored at 340 nm (79.4%), and reported results in U/liter (89.4%). The percentage of laboratories reporting use of reaction temperatures of 30 and 37 #{176}C was evenly divided, i.e., 42.7 and 42%, respectively. Analytical values reported by participating laboratories were categorized by reporting temperature, instrument, and method. Results were most consistent for a selected group of laboratories that supplemented optimized reaction solutions with pyridoxal 5-phosphate.
ported results in U/liter (89.4%). The percentage of laboratories reporting use of reaction temperatures of 30 and 37 #{176}C was evenly divided, i.e., 42.7 and 42%, respectively. Analytical values reported by participating laboratories were categorized by reporting temperature, instrument, and method. Results were most consistent for a selected group of laboratories that supplemented optimized reaction solutions with pyridoxal 5-phosphate. These materials, as used in the present study, were in the form of six lyophilized specimens, which were produced and studied at CDC: two catalytic concentrations of cytoplasmic aspartate aminotransferase purified from human erythrocytes, in a 30 g/liter solution of bovine serum albumin; two catalytic concentrations of cytoplasmic aspartate aminotransferase purified from porcine heart, in a 30 g/liter solution of bovine serum albumin; a matrix blank of bovine serum albumin, 30 g/liter; and a human serum specimen. To obtain a comprehensive data base, we were returned to CDC. In this study we attempted to provide "traceability" to an enzyme material from the time it is isolated and characterized to its eventual use in an interlaboratory study. We give an overview of the experiment in this report; a much more detailed account, soon obtainable from CDC upon request (17) , includes additional information concerning the preparation and stability of aspartate aminotransferase in different matrixes, describes different techniques of compiling the interlaboratory data, and contains information on commercially available kits for measuring aspartate aminotransferase.
Methods and Materials1
Materials Chemicals. Figure 1 , with the following modification. After butanol extraction, 0.4 g of MgC12 and 1 mg of glutathione were added to the aqueous layer, which was dialyzed for 36 h at 4 #{176}C against three changes of a 20-fold volume of de-ionized water. The CM-Sephadex C-50 column (7 12 specimens from each pool were reconstituted with water. Duplicate aspartate aminotransferase measurements were made on all 12 specimens from each pool, with and without pyridoxal 5-phosphate in the reaction solution, immediately after reconstitution, at 1-h intervals for the first 6 h, and finally on subsequent days 1, 2, 5, 6, and 7.
L-Aspartic acid (A grade) and 2-oxoglutaric acid

Intra-run specimento-specimen variation.
Seventy-four days after lyophilization, 12 specimens were selected at random from each pool, and duplicate asparate aminotransferase measurements were made on each reconstituted specimen in the presence and absence of pyridoxal 5-phosphate.
Inter-run specimen-to-specimen variation. Aspartate aminotransferase measurements were performed on single specimens selected at random from each pool on storage days 52, 59, 66, 80, 94, and 185, after lyophilization.
Kinetic Parameters
Km and V
The Michaelis constants (Km) and maximum theoretical velocities (Vm)
were determined as a function of L-aspartate and 2-oxoglutarate concentrations at 30#{176}C, with one substrate concentration being varied and the other held constant at an enzyme-saturating value. Measurements were performed in duplicate on one freshly reconstituted specimen. In addition, these parameters were evaluated with and without pyridoxal 5-phosphate in the reaction mixture. Specifically, with an L-aspartate concentration of 175 mmol/liter, aspartate aminotransferase was measured at 2-oxoglutarate concentrations 
Arrhenius Relationships
The catalytic concentrations of aspartate aminotransferase in all six specimens prepared for this study were measured as a function of temperature at 26.4, 30, and 37 #{176}C. The pH of each reagent was readjusted to the respective reaction temperature before the reaction was initiated. Duplicate determinations were performed on each specimen.
Packages
of specimens identical to those sent to participating laboratories in the interlaboratory part of the study were mailed to six laboratories in various cities in the United States. The selected laboratories subsequently returned the unopened parcels to CDC, where all of the specimens in a parcel were reconstituted and their aspartate aminotransferase activity was measured during a single working day.
Specimen Distribution
On July 12, 1976, one specimen from each pool for the study was sent, at ambient temperatures, to 293 participating laboratories.
Results and Discussion
Characterization of Specimens
Our two criteria for assessing the purity of the isoenzyme isolated from erythrocytes were specific activity and disc gel electrophoretic patterns. Figure 2 shows the change in specific activity during various steps in the purification scheme, for a typical preparation of aspartate aminotransferase isolated from human erythrocytes.
To obtain enough enzyme for this study, we pooled three different dialyzed, butanol-treated fractions before the chromatographic steps. The data on specific activity presented in Figure 2 agree with data from analogous preparations reported by Rej et al. (14) . Disc gel electrophoretograms for both the purified human and porcine cytoplasmic isoenzymes are shown in Figure 3 . Figure 4 shows the gradual decrease in aspartate aminotransferase activity, which eventually leveled off. After 29 days at 37 #{176}C, all specimens were again stored at 4 #{176}C. Figure 5 shows the activity of aspartate aminotransferase in reconstituted specimens stored under the conditions shown in Figure 4 , measured 80 days after lyophilization. The aspartate aminotransferase in these specimens was measured, with and without pyridoxal 5-phosphate added to the reaction solution, during seven days. Figure 5 shows that after reconstitution, specimens containing the purified enzyme initially exhibited about 20% greater activity when pyridoxal 5-phosphate was added to the reaction solution. The activity in the same reconstituted specimens without added cofactor appeared to be relatively stable during the first few hours, but gradually increased to values approaching those measured with pyridoxal 5-phosphate added. The human serum specimen had 95% more activity with pyridoxal 5-phosphate added to the reaction solution; its activity did not change appreciably with time when cofactor was not added. In accord with these findings, the protocol distributed with the specimens for the interlaboratory portion of the study specified that aspartate aminotransferase be measured within one working day after the specimens were reconstituted. Similarly, unless otherwise noted, subsequent studies on these specimens at CDC were performed accordingly. method. These results are compared to those from previous reports in Table 5 . Although different laboratories participated in these studies it is apparent that during the last six years there has been a large apparent increase in the percentage of laboratories using NADH detection methods with concomitant decreases in 2,4-dinitrophenylhydrazine and azoene dye-coupled methods.
In conjunction with the proportion of laboratories using NADH detection methods, a tabulation of questionnaire results in Table 6 
of 490 to 505 nm, five used the 2,4-dinitrophenylhydrazinecoupled methods. Wavelengths ranging from 455 and 530 nm were used to monitor the azoene dye-coupled methods.
Of the 256 laboratories which used NADH detection methods, 120 reported using reaction temperatures of 30#{176}C, and 101 reported using 37 #{176}C, Table 7 . Five of the six laboratories that used azoene dye methods reported using reaction temperatures of 37 #{176}C. In many instances, the reaction temperature selected apparently depended on which manufacturer's kit and the instrument the participant used.
Participants in the interlaboratory study were requested to record the room temperature in the laboratory when the specimens were analyzed. The results ( (Table 10 ). Four out of the five participants who used the method recently described by the International Federation of Clinical Chemistry modified the reagent by omitting pyridoxal 5-phosphate.
; QJ_ C..
.., replies. Participants in the study were asked to report on the physical appearance of each specimen after it was reconstituted (Table 11) . They almost unanimously agreed that specimens prepared in a matrix of bovine serum albumin had no visible turbidity after being reconstituted.
In contrast, most participants noted turbidity in the human serum specimen. Means, standard deviations, and coefficients of variation for analytical data submitted on questionnaires from participating laboratories are shown in Table 12 for all results obtained with NADH detection methods and reported in U/liter. Although conversion factors relating reaction temperatures and different methods have been used by others to convert reports of reaction conditions (14, 15), such a procedure seemed unnecessary in our study because most of the laboratories used NADH methods at reaction temperatures of 30 or 37 #{176}C. When all of the analytical results reported for NADH detection methods were compiled (Table 12) , we found large coefficients of variation, ranging from 32 to 36%, preswnably reflecting the composite effect of analytical variables affecting enzymatic reactions as they are performed in different laboratories at different times (15, 30, 34, 35) . Table 12 also separately lists the NADH detection methods classified in 30 and 37 #{176}C temperature categories. We excluded data reported other than in U/liter and results obtained with the Technicon SMA 12/60, which generally is operated at 37.5 #{176}C.
When the results of the two major reporting temperature categories were analyzed separately, the variances for each category were significantly smaller (by F test) than the vanances for all results combined. The coefficients of variation, however, were of similar magnitude for each particular specimen at both 30 and 37 #{176}C.
In Table 13 Table 13 , the number of different entities appears in parentheses. In some instances, the coefficients of variation listed in Table 13 are smaller than those values in Table 12 , at the same reporting temperature. However, only 26% of the variances in Table 13 are significantly smaller (F test, a = 0.05) than those in Table 12 . By temperature category in Table  13 , no substantial difference in variances was observed among laboratories that used the same instrument and method and those that used either several methods and one instrument or one method and several instruments.
Means in Table 13 Table 12 . We were unable to explain these discrepant results after making a detailed examination of the kit reagent compositions and instrument specifications used to obtain them. Seven selected laboratories performed aspartate aminotransferase measurements with pyridoxal 5-phosphate added to the reaction solution at 30 #{176}C (Table 14) . Each solution also contained optimized concentrations of 2-oxoglutarate and L-aspartate for the cytoplasmic isoenzynle of aspartate aminotransferase (15, 18) . Four different methods and six different instruments were used to obtain the results presented in Table 14 . Coefficients of variation were less than 7% for the specimens containing the purified enzymes in bovine serum albumin, as compared to nearly 20% in Table 12 . Similarly, the coefficient of variation for the human specimen was 5.6% for this group, in contrast with 27% for the group in Table 12 . Means were significantly larger (Student's t -test, a = 0.05) in Table 14 than in Table 12 with the cofactor added to the reaction solution at 30 #{176}C, with the human serum specimen demonstrating the largest apparent activation by the cofactor.
These latter results are in agreement with the effects of pyridoxal 5-phosphate indicated in Table 1 .
In a recent editorial in which he discussed interlaboratory surveys of aspartate aminotransferase by the College of American Pathology, Skendzel (34) stated, "...
after four years of study, it is apparent to me that statistical manipulations of survey data are unlikely to unravel the chaotic state of transaminase assays." However, results shown in Table 14 indicate that close agreement can be reached in interlaboratory measurements under controlled reaction conditions.
Similar observations have been reported by the Scandinavian Society for Clinical Chemistry and Clinical Physiology (35) ; interlaboratory coefficients of variation were as low as 6% when reference methods were used. These findings substantiate those of others (15, 34) who have recommended more accurately defined methods.
Three different sources of aspartate aminotransferase were used in this study. After examining the data gathered at CDC and in the interlaboratory part of this study, we could find no discernible differences between materials prepared from cytoplasmic aspartate aminotransferase purified from human erythrocytes and porcine heart, a conclusion also reached by Rej et al. (22) . The human-serum specimen appeared to respond differently from either of the purified materials in the following instances: reconstitution studies, Figure 5 ; pyridoxal 5-phosphate activation, Table 1 ; Arrhenius data, Table 3 ; specimen clarity, have been produced at CDC and are being characterized by some of the techniques described in this report.
